Entelos, Inc. has announced the completion of a professional services engagement with Bayer AG, to evaluate an IL-4 receptor antagonist as a potential treatment for asthmatics. Entelos applied their predictive asthma PhysioLab technology to Bayer’s proprietary animal model data in order to assess the impact of treatment on a variety of patient types and to Read more about Entelos Evaluates Potential Asthma Treatments For Bayer[…]